Atherogenic Lipoprotein Particles in Atherosclerosis

Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957 · see citing works

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

Ylä‐Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S. S., Witztum, J. L., & Steinberg, D. H. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114271 · Cited by 1,877 · see citing works

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., & Steinberg, D. I. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3883 · Cited by 1,626 · see citing works

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411 · see citing works

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

Walldius, G., Jungner, I., Holme, I., AASTVEIT, A. H., Kolar, W., & Steiner, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07098-2 · Cited by 1,227 · see citing works

A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction

Stampfer, M. J. (1996) · JAMA · doi:10.1001/jama.1996.03540110036029 · Cited by 1,085 · see citing works

Effects of Insulin Resistance and Type 2 Diabetes on Lipoprotein Subclass Particle Size and Concentration Determined by Nuclear Magnetic Resonance

Garvey, W. T., Kwon, S., Zheng, D., Shaughnessy, S., Wallace, P., Hutto, A. C., Pugh, K. B., Jenkins, A. J., Klein, R. L., & Liao, Y. (2003) · Diabetes · doi:10.2337/diabetes.52.2.453 · Cited by 606 · see citing works

Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease

Holvoet, P., Mertens, A. C., Verhamme, P. B., Bogaerts, K., Beyens, G., Verhaeghe, R., Collen, D., Muls, E., & de Werf, F. V. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.5.844 · Cited by 530 · see citing works

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490 · see citing works

Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study

Lamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., & Despre´s, J.-P. (1996) · Circulation · doi:10.1161/01.cir.94.3.273 · Cited by 476 · see citing works

Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?

Steinberg, D. H., & Witztum, J. L. (2002) · Circulation · doi:10.1161/01.cir.0000014762.06201.06 · Cited by 471 · see citing works

Evidence that triglycerides are an independent coronary heart disease risk factor

Cullen, P. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01127-9 · Cited by 462 · see citing works

Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women

Blake, G. J., Otvos, J. D., Rifai, N., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000033222.75187.b9 · Cited by 409 · see citing works

Circulating Oxidized Low Density Lipoprotein Levels

Toshima, S., Hasegawa, A., Kurabayashi, M., Itabe, H., Takano, T., Sugano, J., SHIMAMURA, K., Kimura, J., Michishita, I., Suzuki, T., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.2243 · Cited by 408 · see citing works

Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study)

Hulthe, J., & Fagerberg, B. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000021150.63480.cd · Cited by 346 · see citing works

Relation of Lipoprotein Subclasses as Measured by Proton Nuclear Magnetic Resonance Spectroscopy to Coronary Artery Disease

Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J., & Walker, J. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.7.1046 · Cited by 345 · see citing works

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.

PHILLIPS, N. R., Waters, D. D., & Havel, R. J. (1993) · Circulation · doi:10.1161/01.cir.88.6.2762 · Cited by 345 · see citing works

International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material

Marcovina, S. M., Albers, J. J., Henderson, L. O., & Hannon, W. H. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.5.773 · Cited by 342 · see citing works

Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus

Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 329 · see citing works

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.

Hodis, H. N., Mack, W. J., Azen, S. P., Alaupovic, P., Pogoda, J. M., LaBree, L., Hemphill, L., Kramsch, D. M., & Blankenhorn, D. H. (1994) · Circulation · doi:10.1161/01.cir.90.1.42 · Cited by 321 · see citing works

Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health Study

Kuller, L. H., Arnold, A. M., Tracy, R. P., Otvos, J. D., Burke, G. L., Psaty, B. M., Siscovick, D. S., Freedman, D. S., & Kronmal, R. A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000022015.97341.3a · Cited by 310 · see citing works

The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.

Lamarche, B., Lemieux, I., & Després, J. (1999) · PubMed · Cited by 285 · see citing works

Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease

Kugiyama, K., Doi, H., Takazoe, K., Kawano, H., Soejima, H., Mizuno, Y., Tsunoda, R., Sakamoto, T., Nakano, T., Nakajima, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.22.2858 · Cited by 284 · see citing works

Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease

Vakkilainen, J., Steiner, G. A., Ansquer, J.-C., Aubin, F., Rattier, S., Foucher, C., Hamsten, A., & Taskinen, M. (2003) · Circulation · doi:10.1161/01.cir.0000057982.50167.6e · Cited by 270 · see citing works

International federation of clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of international reference material

Marcovina, S. M., Albers, J. J., Kennedy, H., Mei, J. V., Henderson, L. O., & Hannon, W. H. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.4.586 · Cited by 243 · see citing works

Atherogenicity of Triglyceride-Rich Lipoproteins

Krauss, R. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00032-0 · Cited by 227 · see citing works

Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study

Luc, G., Bard, J., Arveiler, D., Ferrières, J., Evans, A., Amouyel, P., Fruchart, J., & Ducimetière, P. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00026-6 · Cited by 227 · see citing works

Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies

Craig, W. Y., Neveux, L. M., Palomaki, G. E., Cleveland, M. A., & Haddow, J. E. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.11.2301 · Cited by 210 · see citing works

Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men

Sigurðsson, G., Baldursdóttir, Á., Sigvaldason, H., Agnarsson, U., Þorgeirsson, G., & Sigfússon, N. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91215-p · Cited by 187 · see citing works

The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography From a Controlled Clinical Trial

Alaupovic, P., Mack, W. J., Knight‐Gibson, C., & Hodis, H. N. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.4.715 · Cited by 184 · see citing works

Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease

Kwiterovich, P. O., Coresh, J., Smith, H. H., Bachorik, P. S., Derby, C. A., & Pearson, T. A. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90856-t · Cited by 178 · see citing works

Apolipoprotein B and A-I values in 147 576 Swedish males and females, standardized according to the World Health Organization–International Federation of Clinical Chemistry First International Reference Materials

Jungner, I., Marcovina, S. M., Walldius, G., Holme, I., Kolar, W., & Steiner, E. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1641 · Cited by 154 · see citing works

A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.

Lamarche, B., St-Pierre, A., Ruel, I. L., Cantin, B., Dagenais, G. R., & Després, J.-P. (2001) · PubMed · Cited by 142 · see citing works

Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study

SEMAN, L. J., DeLuca, C., Jenner, J. L., Cupples, L. A., McNamara, J. R., Wilson, P. W. F., Castelli, W. P., Ordovás, J. M., & Schaefer, E. J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.1039 · Cited by 138 · see citing works

Quantification of cholesterol in all lipoprotein classes by the VAP-II method.

Kulkarni, K. R., Garber, D. W., Marcovina, S. M., & Segrest, J. P. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40123-3 · Cited by 136 · see citing works

Elevated Remnant-Like Particle Cholesterol and Triglyceride Levels in Diabetic Men and Women in the Framingham Offspring Study

Schaefer, E. J., McNamara, J. R., Shah, P. K., Nakajima, K., Cupples, L. A., Ordovás, J. M., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.989 · Cited by 134 · see citing works

Autoantibodies Against Oxidized Low-Density Lipoprotein and Cardiolipin in Patients With Coronary Heart Disease

Erkkilä, A. T., Närvänen, O., Lehto, S., Uusitupa, M. I. J., & Ylä‐Herttuala, S. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.204 · Cited by 122 · see citing works

Apolipoproteins C–III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Temoins sur 'Infarctus du Myocarde

Luc, G., Fievet, C., Arveiler, D., Evans, A. E., Bard, J. M., Cambien, F., Fruchart, J. C., & Ducimetiere, P. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37594-5 · Cited by 114 · see citing works

Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 Diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study

Soedamah‐Muthu, S. S., Chang, Y., Otvos, J. D., Evans, R. G., & Orchard, T. J. (2003) · Diabetologia · doi:10.1007/s00125-003-1094-8 · Cited by 111 · see citing works

LDL Particle Size Distribution Is Associated With Carotid Intima-Media Thickness in Healthy 50-Year-Old Men

Skoglund-Andersson, C., Tang, R., Bond, M. G., Fairé, U. D., Hamsten, A., & Karpe, F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.10.2422 · Cited by 104 · see citing works

Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins.

Rainwater, D. L., Andres, D., Ford, A., Lowe, F., Blanche, P. J., & Krauss, R. M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41346-x · Cited by 97 · see citing works

Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions

Swinkels, D. W., Hak-Lemmers, H. L. M., & Demacker, P. N. M. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38613-2 · Cited by 91 · see citing works

The Severity of Coronary Atherosclerosis in Type 2 Diabetes Mellitus Is Related to the Number of Circulating Triglyceride-Rich Lipoprotein Particles

Tkáč, I., Kimball, B. P., Lewis, G. F., Uffelman, K. D., & Steiner, G. A. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3633 · Cited by 84 · see citing works

Composition and concentration of apolipoproteins in very-low-and low-density lipoproteins of normal human plasma.

Dm, L., & Alaupovic, P. (1974) · PubMed · Cited by 66 · see citing works

Association Between Carotid Intima-Media Thickness and Low-Density Lipoprotein Size and Susceptibility of Low-Density Lipoprotein to Oxidation in Asymptomatic Members of Familial Combined Hyperlipidemia Families

Liu, M., Ylitalo, K., Nuotio, I. O., Salonen, R., Salonen, J. T., & Taskinen, M. (2002) · Stroke · doi:10.1161/01.str.0000014924.29238.e1 · Cited by 61 · see citing works

Coronary Artery Disease but Not Coronary Calcification Is Associated with Elevated Levels of Cardiolipin, Beta-2-Glycoprotein-I, and Oxidized LDL Antibodies

Sherer, Y., Tenenbaum, A., Praprotnik, S., et al. (2001) · Cardiology · doi:10.1159/000047338 · Cited by 59 · see citing works

High resolution plasma lipoprotein cholesterol profiles by a rapid, high volume semi-automated method.

Chung, B. H., Segrest, J. P., Cone, J. T., Pfau, J. P., Geer, J. C., & Duncan, L. A. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37338-7 · Cited by 50 · see citing works

The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitus

Leinonen, J. S., Rantalaiho, V. M., Laippala, P., Wirta, O., Pasternack, A. I., Alho, H., Jaakkola, O., Ylä‐Herttuala, S., Koivula, T. A., & Lehtimäki, T. J. (1998) · Free Radical Research · doi:10.1080/10715769800300151a · Cited by 30 · see citing works

Measurement of LDL particle size in whole plasma and serum by high performance gel-filtration chromatography using a fluorescent lipid probe

Scheffer, P. G., Bakker, S. J. L., Heine, R. J., & Teerlink, T. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.10.2148 · Cited by 24 · see citing works

Lipoprotein (a)

Durrington, P. N. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80145-6 · Cited by 19 · see citing works

An Efficient Faint Object Spectrograph

Wynne, C. G. (1982) · Optica Acta International Journal of Optics · doi:10.1080/10715769800300151 · Cited by 12 · see citing works

2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Anderson, T. J., Grégoire, J., Pearson, G. J., Barry, A. R., Couture, P., Dawes, M., Francis, G. A., Genest, J., Grover, S., Gupta, M., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.510 · Cited by 1,173 · see citing works

Progression of Age-Related Macular Degeneration: Prospective Assessment of C-Reactive Protein, Interleukin 6, and Other Cardiovascular Biomarkers

Seddon, J. M. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.6.774 · Cited by 354 · see citing works

Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans

Bhutani, S., Klempel, M. C., Kroeger, C. M., Trepanowski, J. F., & Varady, K. A. (2013) · Obesity · doi:10.1002/oby.20353 · Cited by 349 · see citing works

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316 · see citing works

Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis

Mohty, D., Pibarot, P., Després, J.-P., Côté, C., Arsenault, B., Cartier, A., Cosnay, P., Couture, C., & Mathieu, P. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.154989 · Cited by 181 · see citing works

Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia

Gaudet, D., Pall, D., Watts, G. F., Nicholls, S. J., Rosenson, R. S., Modesto, K., San Martin, J., Hellawell, J., & Ballantyne, C. M. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.0959 · Cited by 172 · see citing works

ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age

Mooijaart, S. P., Berbée, J. F. P., van Heemst, D., Havekes, L. M., de Craen, A. J. M., Slagboom, P. E., Rensen, P. C. N., & Westendorp, R. G. J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030176 · Cited by 129 · see citing works

Non-HDL-cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population

van Deventer, H. E., Miller, W. G., Myers, G. L., Sakurabayashi, I., Bachmann, L. M., Caudill, S. P., Dziekonski, A., Edwards, S., Kimberly, M. M., Korzun, W. J., et al. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.154773 · Cited by 112 · see citing works

Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart Disease

Miller, M., Ginsberg, H. N., & Schaefer, E. J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.046 · Cited by 102 · see citing works

Dietary Patterns and Cardiovascular Disease Risk in People with Type 2 Diabetes

Archundia Herrera, M. C., Subhan, F. B., & Chan, C. B. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0284-5 · Cited by 98 · see citing works

Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study

Balling, M., Nordestgaard, B. G., Langsted, A., Varbo, A., Kamstrup, P. R., & Afzal, S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.072 · Cited by 73 · see citing works

Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study

Arsenault, B. J., Lemieux, I., Despres, J.-P., Wareham, N. J., Luben, R., Kastelein, J. J. P., Khaw, K.-T., & Boekholdt, S. M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm390 · Cited by 63 · see citing works

Noninvasive detection of coronary artery disease--challenges for prevention of disease and clinical events

da Luz, P. L., Bertini, P. J., & Favarato, D. (2005) · Clinics · doi:10.1590/s1807-59322005000500011 · Cited by 13 · see citing works

Abstract 484: Apolipoprotein (a) Isoform Size Regulates Both the Production and Clearance of Circulating Lipoprotein (a)

Matveyenko, A., Ngai, C. I., Thomas, T., Nandakumar, R., Marcovina, S. M., Holleran, S., Ramakrishnan, R., Ginsberg, H. N., & Reyes‐Soffer, G. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvb.39.suppl_1.484

[Autoantibodies against lipoprotein(a) in patients with coronary heart disease].

Афанасьева, О. И., Klesareva, E. A., Pa, L., et al. (2014) · PubMed · Cited by 4 · see citing works

Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions.

Zorio, E., Falcó, C., Arnau, M. Á., España, F., Osa, A., Ramón, L., Castelló, R., Almenar, L., Palencia, M. A., & Estellés, A. (2006) · PubMed · Cited by 22 · see citing works

Determination of Lp(a) and APO(a) in an Italian population

Cuchel, M., Merati, G., Clerici, M., et al. (1991) · La Ricerca in Clinica e in Laboratorio · doi:10.1007/bf02919122 · Cited by 2 · see citing works

Kinetics of apolipoproteins A-I and A-II

Zech, L. A., Schaefer, E. J., Osborne, J. C., et al. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2793-6_17